Protection of dopaminergic cells by urate requires its accumulation in astrocytes
Authors:
- 22 August 2012
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 123 (1) , 172-181
Abstract
Urate is the end product of purine metabolism and a major antioxidant circulating in humans. Recent data link higher levels of urate with a reduced risk of developing Parkinson’s disease and with a slower rate of its progression. In this study, we investigated the role of astrocytes in urate‐induced protection of dopaminergic cells in a cellular model of Parkinson’s disease. In mixed cultures of dopaminergic cells and astrocytes oxidative stress‐induced cell death and protein damage were reduced by urate. By contrast, urate was not protective in pure dopaminergic cell cultures. Physical contact between dopaminergic cells and astrocytes was not required for astrocyte‐dependent rescue as shown by conditioned medium experiments. Urate accumulation in dopaminergic cells and astrocytes was blocked by pharmacological inhibitors of urate transporters expressed differentially in these cells. The ability of a urate transport blocker to prevent urate accumulation into astroglial (but not dopaminergic) cells predicted its ability to prevent dopaminergic cell death. Transgenic expression of uricase reduced urate accumulation in astrocytes and attenuated the protective influence of urate on dopaminergic cells. These data indicate that urate might act within astrocytes to trigger release of molecule(s) that are protective for dopaminergic cells.Keywords
This publication has 41 references indexed in Scilit:
- Astrocytes and Therapeutics for Parkinson's DiseaseNeurotherapeutics, 2010
- Uric acid promotes an acute inflammatory response to sterile cell death in miceJournal of Clinical Investigation, 2010
- Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's diseaseNeuroscience, 2010
- Therapeutic directions for Parkinson's diseaseMovement Disorders, 2010
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson DiseaseArchives of Neurology, 2009
- Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathyProceedings of the National Academy of Sciences, 2009
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson DiseaseArchives of Neurology, 2008
- Plasma Urate and Risk of Parkinson's DiseaseAmerican Journal of Epidemiology, 2007
- Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: Relevance to oxidative damage in Parkinson's diseaseNeurochemistry International, 2007
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences, 1981